These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3004383

  • 21. Peripheral nerve phospholipids in acrylamide neuropathy.
    Howland RD, Lowndes HE.
    Arch Toxicol; 1984 Sep; 55(3):178-81. PubMed ID: 6093740
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Relative refractory period as a measure of peripheral nerve neurotoxicity.
    Anderson RJ.
    Toxicol Appl Pharmacol; 1983 Dec; 71(3):391-7. PubMed ID: 6318389
    [Abstract] [Full Text] [Related]

  • 25. Changes in Na-K ATPase and protein kinase C activities in peripheral nerve of acrylamide-treated rats.
    Lehning EJ, LoPachin RM, Mathew J, Eichberg J.
    J Toxicol Environ Health; 1994 Jul; 42(3):331-42. PubMed ID: 8021966
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Acrylamide neuropathy: changes in the composition of proteins of fast axonal transport resemble those observed in regenerating axons.
    Bisby MA, Redshaw JD.
    J Neurochem; 1987 Mar; 48(3):924-8. PubMed ID: 2433402
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Biochemical and morphologic characterization of acrylamide peripheral neuropathy.
    Lehning EJ, Persaud A, Dyer KR, Jortner BS, LoPachin RM.
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):211-21. PubMed ID: 9707497
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Acid hydrolases in brain, spinal cord and sciatic nerves of acrylamide-intoxicated rats.
    Srivastava SP, Srivastava SP, Seth PK.
    Toxicol Lett; 1984 Aug; 22(2):211-5. PubMed ID: 6474510
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A catechol derivative (4-methylcatechol) accelerates the recovery from experimental acrylamide-induced neuropathy.
    Saita K, Ohi T, Hanaoka Y, Furukawa S, Furukawa Y, Hayashi K, Matsukura S.
    J Pharmacol Exp Ther; 1996 Jan; 276(1):231-7. PubMed ID: 8558436
    [Abstract] [Full Text] [Related]

  • 38. Alterations in the neutral proteinase activities of central and peripheral nervous systems of acrylamide-, carbon disulfide-, or 2,5-hexanedione-treated rats.
    Gupta RP, Abou-Donia MB.
    Mol Chem Neuropathol; 1996 Sep; 29(1):53-66. PubMed ID: 8887940
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A simple, sensitive method for detecting early peripheral nerve dysfunction in the rat following acrylamide treatment.
    Miller MJ, Miller MS, Burks TF, Sipes IG.
    Neurotoxicology; 1984 Sep; 5(2):15-23. PubMed ID: 6095142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.